ExosomeLife Presents Exsosome Bank with ExoIntel™ Platform: Next Generation Therapeutics

ExosomeLife, an emerging biotech company, has patent-applied-for proprietary technologies which advance the state of the art in the field of exosome research. One such advance in this new therapeutic field of medicine is its first solution in the exosome field which include an ExoBank™ and ExoIntel™.

LAS VEGAS (PRWEB) April 30, 2018

ExosomeLife has developed a new way of establishing clinical-grade exosome banks under its trademark ExoBank™ by making breakthroughs in proprietary methods to manufacture, purify and engineer exosomes in a more efficient, faster, and much less costly manner.

ExosomeLife has developed a method to increase the stability of exosomes and keep their potencies over long periods of time using its ExoBank™ proprietary methodology. The ExoBank™ methodology would have the capacity to store clinical-grade, quality-controlled exosomes for extended periods of time for therapeutic purposes.

About ExosomeLife LLC
ExosomeLife LLC is a privately held biotechnology company dedicated to creating next generation therapeutics for patients through its patent-applied-for and proprietary platform of ExoIntel™ and through its breakthrough technology of storage using its ExoBank™ platform. ExosomeLife is determined to bring economic cures and treatments for diseases that impair quality of life for millions of people around the globe.

Contact Information
ExosomeLife LLC
info@exosomelife.com
+1 (702) 722-7177

For the original version on PRWeb visit: http://www.prweb.com/releases/2018/04/prweb15450760.htm